Nephrologist UC Davis, CA
Sacramento, CA
Joined September 2014
- Tweets296
- Following127
- Followers182
- Likes268
If @DGlaucomflecken does summaries for all NEJM trials, I’ll never miss another one ! This is a gem of an idea !!
Our new partnership with @DGlaucomflecken has begun!
Visit our new TikTok channel for his first video featuring Bug Bro and Ortho as they discuss whether iodine or chlorhexidine is better for surgical prep of an extremity fracture: tiktok.com/@nejm.org/video/7…
Shubha Ananthakrishn retweeted
Proud of the collaborative work of Program Directors including my own UCDavis Dr. Brian Young and UofA Dr. Amy Sussman, for landing front cover of this month’s CJASN, calling for protected administrative time to do the work that is essential for a thriving fellowship experience👏
Shubha Ananthakrishn retweeted
Splendid show at the @UCD_IM Department Academic Forum! Multiple awards! Dr. Young w/ outstanding clinician, 1st yr fellow @raymadhab + grad student Armin w/ research (Dr. Bob @broshan = super mentor), and 2nd yr fellow @justkidneying23 w/ clinical case! #nephtwitter #nephrology
Shubha Ananthakrishn retweeted
Congratulations Dr Roshanravan @broshan ! We hugely appreciate all the work you do for our patients and advancing our scientific community! Looking forward to your editorial contributions with @CJASN. Thank you @broshan !
CJASN is pleased to announce the incoming Editorial Team, under the direction of EIC @ConnieMRhee, effective January 1, 2024
@sagarnigs @kamkalantar @KatherineTuttl8 @ChrisChanUHN @keepingitrenal @J_B_Kendrick @LaetitiaKoppe @MBaliker @gratefull080504
ALT Incoming CJASN Editorial Team
Shubha Ananthakrishn retweeted
🌟 Faculty Spotlight 🌟 Dr. Brian Young, our Fellowship PD!
Grew up in California’s cantaloupe capital, but allergic to cantaloupe! 😄
Passionate about electrolytes & mentoring future nephrologists. Enjoys videogaming with family & exploring Sacramento’s food scene.
#NephTwitter
Shubha Ananthakrishn retweeted
🌟Fellow Spotlight🌟 Kristen Pietrzyk, 2nd Year. Look at those notes on RAAS! Hometown: Reno, NV. Recent Nephro Interest: Optimizing the dialysis patient experience. Favorite Sacramento Thing: As a central hub for all things travel, food, activities, outdoors, etc. #NephTwitter
Shubha Ananthakrishn retweeted
🎉 Excited to welcome Dr. Amrita Asha Mahesh, DO, MSc as our #TransplantNephrology Fellow! (From UCSF Neph Fellowship). With her unique journey as a kidney transplant recipient, she brings compassion and expertise to care for pts transitioning from pediatric to adult. Welcome!!
Co-authored by our faculty @kishorkapa ! @UCDNephrology
2023 July @KidneyNews The Nephrologist's Role in Supporting and Promoting Lactation by Anna Sadovnikova and Nandakishor Kapa kidneynews.org/view/journals…
Shubha Ananthakrishn retweeted
2023 July @KidneyNews The Nephrologist's Role in Supporting and Promoting Lactation by Anna Sadovnikova and Nandakishor Kapa kidneynews.org/view/journals…
Shubha Ananthakrishn retweeted
Hey #NephTwitter #Medtwitter!
⚠️How often do you see a family of cases with nephrotic syndrome?
💭What are your first thoughts when multiple family members present with glomerular disease?
Read along!
Here's an intriguing series of cases we encountered some time ago!👇🏻1/n
Shubha Ananthakrishn retweeted
We are proud of our nephrology team for receiving the Dean’s Award for Excellence in Team Inclusion 2022, for being among the first to eliminate race-based eGFR reporting, in collaboration with @UCDPath, @UCD_IM, and @UCDavis_Nursing.
@UCDavisHealth @broshan
Shubha Ananthakrishn retweeted
Thank you @NWiegley for a masterful talk on C3 glomerulopathy this morning! @UCDNephrology
Shubha Ananthakrishn retweeted
PCSK6 appears as the likely MN target antigen associated with chronic NSAID use.
Keep in mind that most pts with NSAID use do not have MN, or pts with MN may h/o NSAID use & are PCSK6 negative.
On other hand, most cases of PCSK6-MN have h/o NSAID use.
doi.org/10.1016/j.kint.2023.… – at Gangnam-gu, Republic of Korea
Shubha Ananthakrishn retweeted
ICYMI: A clinical trial has begun using CAR T cells to potentially cure HIV! We're proud to be a part of this incredibly important research with our friends at @UCSF! health.ucdavis.edu/internal-…
Shubha Ananthakrishn retweeted
Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases - Gangat - American Journal of Hematology - Wiley Online Library onlinelibrary.wiley.com/doi/…
Shubha Ananthakrishn retweeted
The lonely Warrior fans (including our APD and PD, Dr Ananthakrishnan and Dr Young) living a moment, while teaching about secondary hypertension to a sea of @SacramentoKings fans as part of the @UCDavisMed MS1 renal physiology course.
#KingsvsWarriors
What a great time with @kidney_boy!! @UCDNephrology fellows had a blast with the one and only kidney boy … he even autographed a kidney for @novel_nephro ! Thank you Joel for a wonderful and hilarious time!
Shubha Ananthakrishn retweeted
#NephMadness Excitement has officially started @UCDNephrology!!! 🥳
2 of our wonderful fellows started the festivities with discussing the #IgAN (Dr. Kristen Pietrzyk) & #Onconeph brackets. (@lucjmoreno2)
Can’t wait to continue the rest of the topics!
#NephTwitter
Shubha Ananthakrishn retweeted
Our recent pub in @amjhypertension on the prevalence of non-adherence in resistant hypertension academic.oup.com/ajh/advance…
Thread over on 🐘:
med-mastodon.com/@hswapnil/1…
Shubha Ananthakrishn retweeted
Who’s up for Friday Tandoori Rounds? 😃
#GreatConsultTeams #TastyFoodAndGreatDiscussions #Nephrology #Fellowship #NephTwitter
